ストックスクリーナーアプリを入手
1.60
1.23%
-0.02
アフターアワーズ：
1.59
-0.01
-0.63%
前日終値:
$1.62
開ける：
$1.6
24時間の取引高:
340.57K
Relative Volume:
0.43
時価総額：
$127.57M
収益：
$63.63M
当期純損益:
$10.62M
株価収益率:
32.00
EPS:
0.05
ネットキャッシュフロー:
$-8.64M
1週間 パフォーマンス:
+1.91%
1か月 パフォーマンス:
+5.96%
6か月 パフォーマンス:
-31.33%
1年 パフォーマンス:
+75.55%
1日の値動き範囲:
$1.58
$1.62
1週間の範囲:
$1.539
$1.66
52週間の値動き範囲:
$0.89
$3.10
Protalix BioTherapeutics Inc. Stock (PLX) Company Profile
名前
Protalix BioTherapeutics Inc.
セクター
電話
972 4 988 9488
住所
2 Snunit Street, Science Park PO Box 455, Karmiel
PLX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PLX
Protalix BioTherapeutics Inc.
|
1.60 | 127.57M | 63.63M | 10.62M | -8.64M | 0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.50 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Protalix BioTherapeutics Inc. Stock (PLX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-06-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-04-17 | 繰り返されました | Rodman & Renshaw | Buy |
| 2016-04-04 | 開始されました | Rodman & Renshaw | Buy |
| 2015-04-23 | アップグレード | Jefferies | Hold → Buy |
| 2014-11-12 | 繰り返されました | R. F. Lafferty | Buy |
| 2014-01-24 | 開始されました | R. F. Lafferty | Buy |
| 2012-05-02 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2012-05-02 | 繰り返されました | Oppenheimer | Outperform |
| 2012-04-30 | ダウングレード | Auriga | Buy → Hold |
| 2011-10-13 | 開始されました | Morgan Joseph | Hold |
| 2011-03-17 | ダウングレード | WBB Securities | Strong Buy → Buy |
| 2010-11-09 | 繰り返されました | Oppenheimer | Outperform |
| 2010-10-14 | 繰り返されました | UBS | Buy |
| 2009-12-02 | 繰り返されました | Hapoalim | Outperform |
| 2009-09-22 | 開始されました | Canaccord Adams | Buy |
| 2009-09-02 | 開始されました | Hapoalim | Outperform |
| 2008-12-01 | 繰り返されました | Oppenheimer | Outperform |
| 2008-03-11 | 開始されました | UBS | Buy |
| 2007-11-20 | 開始されました | CIBC Wrld Mkts | Sector Outperform |
すべてを表示
Protalix BioTherapeutics Inc. (PLX) 最新ニュース
What’s the recovery path for long term holders of Protalix BioTherapeutics Inc.July 2025 Decliners & Reliable Momentum Entry Alerts - Newser
Historical volatility pattern of Protalix BioTherapeutics Inc. visualizedWall Street Watch & Low Risk Growth Stock Ideas - Newser
Will Protalix BioTherapeutics Inc. price bounce be sustainable2025 Market WrapUp & Accurate Buy Signal Alerts - Newser
Quantitative breakdown of Protalix BioTherapeutics Inc. recent moveM&A Rumor & Daily Stock Trend Reports - Newser
Is It Too Late to Sell Protalix BioTherapeutics Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Best data tools to analyze Protalix BioTherapeutics Inc. stockTrade Risk Report & Community Consensus Stock Picks - Newser
Trend analysis for Protalix BioTherapeutics Inc. this weekWeekly Earnings Recap & Risk Adjusted Buy/Sell Alerts - Newser
How high can Protalix BioTherapeutics Inc. stock goJuly 2025 Setups & Risk Managed Investment Signals - Newser
Does Protalix BioTherapeutics Inc. fit your quant trading modelGap Up & High Accuracy Investment Entry Signals - Newser
Why Protalix BioTherapeutics Inc. is moving today2025 Trading Volume Trends & Entry Point Confirmation Signals - Newser
What machine learning models say about Protalix BioTherapeutics Inc.Exit Point & Safe Entry Trade Signal Reports - Newser
Analysts Spot Bullish Divergence in Protalix BioTherapeutics Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Applying sector rotation models to Protalix BioTherapeutics Inc.2025 Biggest Moves & Short-Term Trading Opportunity Alerts - Newser
What MACD signals say about Protalix BioTherapeutics Inc2025 Major Catalysts & Reliable Entry Point Trade Alerts - Newser
Analyzing Protalix BioTherapeutics Inc. with multi timeframe chartsPortfolio Value Report & Low Risk High Win Rate Stock Picks - Newser
Forecasting Protalix BioTherapeutics Inc. price range with options dataJuly 2025 Outlook & Long-Term Investment Growth Plans - Newser
Key resistance and support levels for Protalix BioTherapeutics Inc.Index Update & Fast Exit/Entry Strategy Plans - Newser
Protalix: Speculative Buy On Promising Plant-Cell Platform And Elfabrio Ramp (NYSE:PLX) - Seeking Alpha
Will Protalix BioTherapeutics Inc. bounce back from current supportJuly 2025 Big Picture & Weekly Top Gainers Alerts - Newser
What MACD signals say about Protalix BioTherapeutics Inc.July 2025 Fed Impact & Daily Growth Stock Tips - Newser
Using data tools to time your Protalix BioTherapeutics Inc. exit2025 Key Highlights & Entry Point Confirmation Alerts - Newser
Chart based analysis of Protalix BioTherapeutics Inc. trendsLayoff News & Verified Momentum Stock Alerts - Newser
Can machine learning forecast Protalix BioTherapeutics Inc. recoveryBuy Signal & Fast Moving Stock Watchlists - Newser
Revenue Check: Is Protalix BioTherapeutics Inc. exposed to currency risks2025 Macro Impact & Verified Trade Idea Suggestions - sundaytimes.kr
How to use a screener to detect Protalix BioTherapeutics Inc. breakoutsJuly 2025 Trends & Real-Time Chart Breakout Alerts - Newser
Trapped Investors in Protalix BioTherapeutics Inc. Await Breakout SignalJuly 2025 Gainers & AI Enhanced Trade Execution Alerts - beatles.ru
Protalix Amends Market Offering Agreement with H.C. Wainwright for Equity Program - AInvest
Protalix BioTherapeutics amends at-the-market equity offering agreement By Investing.com - Investing.com Nigeria
Protalix BioTherapeutics amends at-the-market equity offering agreement - Investing.com
Protalix Amends Market Offering Agreement with H.C. Wainwright - TipRanks
Aug Action: Can Protalix BioTherapeutics Inc. deliver consistent EPS growthTake Profit & Growth Focused Stock Reports - sundaytimes.kr
Exit strategy if you’re trapped in Protalix BioTherapeutics Inc.Trade Analysis Report & Proven Capital Preservation Methods - Newser
Fibonacci Retracement Aligns with Support in Protalix BioTherapeutics Inc.2025 Analyst Calls & Fast Entry High Yield Tips - beatles.ru
What machine learning models say about Protalix BioTherapeutics IncTrade Performance Summary & AI Forecast for Swing Trade Picks - Newser
Protalix BioTherapeutics Inc. stock momentum explained2025 Sector Review & Community Shared Stock Ideas - Newser
Chart overlay techniques for tracking Protalix BioTherapeutics Inc.2025 Technical Overview & Reliable Breakout Forecasts - Newser
Key External Factors That Drive Protalix BioTherapeutics Inc. Stock Price MovementsPortfolio Profit Report & Fast Gain Swing Alerts - Newser
Protalix signals $100M+ Elfabrio royalties by 2030 as Phase II PRX-115 trial advances - MSN
How Protalix BioTherapeutics Inc. stock reacts to Fed policy changesSell Signal & Growth Focused Entry Reports - Newser
Why Protalix BioTherapeutics Inc. stock attracts strong analyst attentionMarket Sentiment Summary & Reliable Entry Point Alerts - Newser
Key metrics from Protalix BioTherapeutics Inc.’s quarterly dataMarket Volume Report & Free Community Consensus Stock Picks - Newser
Protalix BioTherapeutics Inc. (PLX) 財務データ
収益
当期純利益
現金流量
EPS
0.98%
8.06%
大文字化:
|
ボリューム (24 時間):